Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts
Guillermo Ruiz‐Irastorza(BioCruces Health research Institute), Patrick Blanco(Centre National de la Recherche Scientifique), Ramon Saenz(BioCruces Health research Institute), Christophe Richez(Centre National de la Recherche Scientifique), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Amalur Iza(BioCruces Health research Institute), Cécile Saint-Pastou Terrier(Hôpital Cardiologique du Haut-Lévêque), Sabrina Porta(BioCruces Health research Institute), Amaia Ugarte(BioCruces Health research Institute), Lionel Couzi(Université de Bordeaux)
Cited by 84
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414